Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

Summary

This phase II trial studies how well giving fluocinonide cream works in treating symptoms of vaginal dryness and painful sexual intercourse in patients with breast cancer undergoing hormone therapy. Fluocinonide cream may prevent or lessen vaginal dryness and painful sexual intercourse in patients undergoing hormone therapy.

Timeline

Start

2011-09

Primary completion

2015-10

Completion

2015-10

Outcome

Met primary endpoint

registry p <0.001; Wilcoxon (Mann-Whitney) NCT01422408 ↗

registry p = 0.002; Wilcoxon (Mann-Whitney) NCT01422408 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fluocinonide	Other / unclassified	0.05 %	Topical

Indications